Gene-IT Announces Biosite Licensing of GenomeQuest™Wednesday, January 3rd, 2007
Leader in sequence search provides solution to research-based provider of novel diagnostics.
Westborough, Massachusetts - January 3, 2007 – Gene-IT, a leader in sequence search, today announced that it is providing its flagship GenomeQuest™ service to Biosite Incorporated (Nasdaq: BSTE), a research-based provider of novel, rapid medical diagnostics.
GenomeQuest™ is a sequence search solution that enables biologists to evaluate novel gene sequences, and allows IP lawyers to evaluate freedom-to-operate, patentability, and competitive landscape features for the same sequences. The solution uniquely combines easy-to-use sequence search and analytics with public and proprietary sequence content, including the industry's largest and most complete indexed archive of more than 30 million patented sequences.
"Developing new diagnostic products requires considerable effort and time and we have to understand the patent landscape for our sequences of interest," said Michael Whittaker, Biosite's vice president of intellectual properties. "With GenomeQuest, we can search against the expanding patent landscape in a minimum of time and with a high level of confidence that we can find the 'needle in the haystack.'"
Ronald Ranauro, president and chief executive officer of Gene-IT, said, "Molecular diagnostics is the next frontier for applied genomics technologies and we are thrilled that Biosite has elected to use GenomeQuest search for their patent search workflow."
About Gene-IT
Gene-IT's innovative sequence search technology provides relevant answers to questions about the human genome asked by scientists and attorneys today, and by clinicians and physicians in the future. The company's flagship product, GenomeQuest, is an easy-to-use Web-based application that integrates, mines and analyzes sequence data from dozens of scientific and patent sources worldwide. GenomeQuest's proprietary sequence search capabilities help the world's leading pharmaceutical and biotechnology companies make faster and more accurate decisions on their gene and protein discoveries. Its automated alerting, report publishing and knowledge-sharing capabilities enhance the productivity of all users. Gene-IT is headquartered in Westborough, Massachusetts. For more information, please call (508) 616-0100, or visit our web site: www.genomequest.com. |
